Mirxes Launches Up to HK$1.1 Billion Hong Kong IPO

MT Newswires

2025/05/15

Mirxes (HKG:2629) launched its initial public offering in Hong Kong Thursday, seeking to raise up to HK$1.09 billion from the deal.

The Singapore-headquartered micro ribonucleic acid technology company is offering up to 46,620,000 at HK$23.30 per share, according to a Thursday filing with the Hong Kong Stock Exchange.

Mirxes will disclose allocation results on May 22. Shares will begin trading on the stock exchange on May 23.

The micro RNA technology company intends to use the proceeds for research and development for its core cancer screening product GASTROClear and its pipeline products, integration of its end-to-end capabilities, and for working capital.

Mirxes attracted Beijing Xunrui and Evergreen Gate as cornerstone investor.

China International Capital Corp. Hong Kong Securities, CCB International Capital, CMBC Securities, CMB International Capital, Soochow Securities International, Livermore Holdings, BOCOM International Securities, and Platinum Broking, are the joint bookrunners and lead managers of the IPO.

Waton Securities International, Alpha Win Capital, Imperium International Securities, Kingkey Securities Group, and Yuen Meta (International), are also joint lead managers of the offering.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2535853155"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535853155\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535853155?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-15 11:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535853155","market":"sg","top_or_hot":-1,"title":"Mirxes Launches Up to HK$1.1 Billion Hong Kong IPO","media":"MT Newswires","content":"<html><body><p> Mirxes (HKG:2629) launched its initial public offering in Hong Kong Thursday, seeking to raise up to HK$1.09 billion from the deal.</p><p>The Singapore-headquartered micro ribonucleic acid technology company is offering up to 46,620,000 at HK$23.30 per share, according to a Thursday filing with the Hong Kong Stock Exchange.</p><p>Mirxes will disclose allocation results on May 22. Shares will begin trading on the stock exchange on May 23.</p><p>The micro RNA technology company intends to use the proceeds for research and development for its core cancer screening product GASTROClear and its pipeline products, integration of its end-to-end capabilities, and for working capital.</p><p>Mirxes attracted Beijing Xunrui and Evergreen Gate as cornerstone investor.</p><p>China International Capital Corp. Hong Kong Securities, CCB International Capital, CMBC Securities, CMB International Capital, Soochow Securities International, Livermore Holdings, BOCOM International Securities, and Platinum Broking, are the joint bookrunners and lead managers of the IPO.</p><p>Waton Securities International, Alpha Win Capital, Imperium International Securities, Kingkey Securities Group, and Yuen Meta (International), are also joint lead managers of the offering.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mirxes Launches Up to HK$1.1 Billion Hong Kong IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMirxes Launches Up to HK$1.1 Billion Hong Kong IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1060499803\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires </p>\n<p class=\"h-time\">2025-05-15 11:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Mirxes (HKG:2629) launched its initial public offering in Hong Kong Thursday, seeking to raise up to HK$1.09 billion from the deal.</p><p>The Singapore-headquartered micro ribonucleic acid technology company is offering up to 46,620,000 at HK$23.30 per share, according to a Thursday filing with the Hong Kong Stock Exchange.</p><p>Mirxes will disclose allocation results on May 22. Shares will begin trading on the stock exchange on May 23.</p><p>The micro RNA technology company intends to use the proceeds for research and development for its core cancer screening product GASTROClear and its pipeline products, integration of its end-to-end capabilities, and for working capital.</p><p>Mirxes attracted Beijing Xunrui and Evergreen Gate as cornerstone investor.</p><p>China International Capital Corp. Hong Kong Securities, CCB International Capital, CMBC Securities, CMB International Capital, Soochow Securities International, Livermore Holdings, BOCOM International Securities, and Platinum Broking, are the joint bookrunners and lead managers of the IPO.</p><p>Waton Securities International, Alpha Win Capital, Imperium International Securities, Kingkey Securities Group, and Yuen Meta (International), are also joint lead managers of the offering.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02629","symbol_name":"MIRXES-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2535853155","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535853155","pubTimestamp":1747278178,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Mirxes  launched its initial public offering in Hong Kong Thursday, seeking to raise up to HK$1.09 billion from the deal.The Singapore-headquartered micro ribonucleic acid technology company is offering up to 46,620,000 at HK$23.30 per share, according to a Thursday filing with the Hong Kong Stock Exchange.Mirxes will disclose allocation results on May 22. Shares will begin trading on the stock exchange on May 23.The micro RNA technology company intends to use the proceeds for research and development for its core cancer screening product GASTROClear and its pipeline products, integration of its end-to-end capabilities, and for working capital.Mirxes attracted Beijing Xunrui and Evergreen Gate as cornerstone investor.China International Capital Corp. Hong Kong Securities, CCB International Capital, CMBC Securities, CMB International Capital, Soochow Securities International, Livermore Holdings, BOCOM International Securities, and Platinum Broking, are the joint bookrunners and lead man","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02629":"MIRXES-B"},"translate_title":"Mirxes启动高达11亿港元的香港IPO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02629":0.9},"content_text":"Mirxes (HKG:2629) launched its initial public offering in Hong Kong Thursday, seeking to raise up to HK$1.09 billion from the deal.The Singapore-headquartered micro ribonucleic acid technology company is offering up to 46,620,000 at HK$23.30 per share, according to a Thursday filing with the Hong Kong Stock Exchange.Mirxes will disclose allocation results on May 22. Shares will begin trading on the stock exchange on May 23.The micro RNA technology company intends to use the proceeds for research and development for its core cancer screening product GASTROClear and its pipeline products, integration of its end-to-end capabilities, and for working capital.Mirxes attracted Beijing Xunrui and Evergreen Gate as cornerstone investor.China International Capital Corp. Hong Kong Securities, CCB International Capital, CMBC Securities, CMB International Capital, Soochow Securities International, Livermore Holdings, BOCOM International Securities, and Platinum Broking, are the joint bookrunners and lead managers of the IPO.Waton Securities International, Alpha Win Capital, Imperium International Securities, Kingkey Securities Group, and Yuen Meta (International), are also joint lead managers of the offering.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}